Abstract
We conducted a cross-sectional, geographically based study of functional status in an incident cohort of 124 multiple sclerosis (MS) patients with onset of disease from 1 January 1976 to 31 December 1986 in Møre and Romsdal County, Norway. The cohort comprised 58 men (46.8%) and 66 women (53.2%). One hundred and thirteen patients (91.1 %) had a primary remitting course of disease and 11 (8.9%) had primary progressive MS. The mean age of onset was 33.3 years (range 14–64), and the mean duration of disease 7.8 years (range 1–23). The Minimal Record of Disability (MRD) of multiple sclerosis was applied to measure the degree of impairment, disability and handicap. The mean Kurtzke Expanded Disability Status Scale (EDSS) score was 3.76 (0–10), and the frequency distribution of the EDSS scores in the cohort was bimodal. Twenty-eight (22.6%) patients in the cohort had marked paraparesis, paraplegia or quadriplegia. Nineteen patients (15.3%) had frequent urinary incontinence, need for almost constant catheterization, or need for constant use of measures to evacuate stools. Five patients (4%) had a severe decrease in mentation or dementia. Forty-eight patients (38.7%) reported frequent problems with fatigue or fatigability preventing sustained physical function. Less than half of the cohort (42.7%) was working fulltime, and 49.2% of the patients reported that they received external support to maintain their usual financial standard. Lack of ability to work full-time and accordingly the dependence upon external financial support were significantly associated with the primary progressive course of disease. Fatigue was statistically significantly related to lack of working ability. The estimated cost of MS in the county in 1991 was 48.2 million NOK (≈ 7.531.250 US $) based on the cost-of-illness methodology.
Similar content being viewed by others
References
Ammann W, Plohmann A, Roelcke U, Leenders KL, Lechner-Scott J, Huber S, Kappos L (1995) Assessment of fatigue in multiple sclerosis (MS), correlation with neurological and neuropsychological findings. J Neurol 242 [Suppl 2]: S119
Bauer HJ (1980) IMAB Enquete concerning the diagnosis criteria for MS. In: Bauer HJ, Poser S, Ritter G (eds) Progress in multiple sclerosis research. Springer, Berlin Heidelberg New York, pp 555–563
Bergamaschi R, Romani A, Zilioli A, Raiola E, Versino M, Cosi V (1995) Fatigue and motor impairment in 100 multiple sclerosis patients. J Neurol 242 [Suppl 2]: S112
Grønning M, Hannisdal E, Mellgren SI (1990) Multivariate analyses of factors associated with unemployment in people with multiple sclerosis. J Neurol Neurosurg Psychiatry 53:388–390
Hodgson TA, Meiners MR (1982) Cost-of-illness methodology: a guide to current practices and procedures. Milbank Memorial Fund Quarterly/Health and Society 60 (3):429–462
Hohol MJ, Orav EJ, Weiner HL (1995) Disease Steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology 45:251–255
Hutchinson J, Hutchinson M (1995) The Functional Limitations Profile may be a valid, reliable and sensitive measure of disability in multiple sclerosis. J Neurol 242:650–657
Jönsson B (1995) The economic cost of multiple sclerosis in Sweden. EFI Research Paper no. 6551
Kornblith AB, LaRocca NG, Baum HM (1986) Employment in individuals with multiple sclerosis. Int J Rehabil Res 9:155–165
Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437
Kurtzke JF (1955) A new scale for evaluating disability in multiple sclerosis. Neurology 5:580–583
Kurtzke JF (1989) The Disability Status Scale for multiple sclerosis: apologia pro DSS sua. Neurology 39:291–302
LaRocca J, Kalb R, Scheinberg L, Kendall P (1985) Factors associated with unemployment of patients with multiple sclerosis. J Chronic Dis 38:203–210
LaRocca NG, Scheinberg LC, Slater RJ, et al (1984) Field testing of a minimal record of disability in multiple sclerosis: the United States and Canada. Acta Neurol Scand [Suppl] 101:126–138
MacLean AR, Berkson J (1951) Mortality and disability in multiple sclerosis. A statistical estimate of prognosis. JAMA 15:1367–1369
Martyn CN (1991) The epidemiology of multiple sclerosis. In: Matthews WB, Compston A, Allen IV, Martyn CN (eds) McAlpine's multiple sclerosis. Churchill Livingstone, Edinburgh, pp 9–10
Matthews WB (1985) Clinical aspects. Course and prognosis. In: Matthews WB, Acheson ED, Batchelor JR, Weller RO (eds) McAlpine's multiple sclerosis. Churchill Livingstone, Edinburgh, pp 49–72
Midgard R, Riise T, Nyland H (1991) Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 41:887–892
Midgard R, Riise T, Kvåle G, Nyland H (in press) Disability and mortality in multiple sclerosis in Western Norway. Acta Neurol Scand
Midgard R, Albrektsen G, Riise T, Kvåle G, Nyland H (1995) Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway. J Neurol Neurosurg Psychiatry 58:417–421
Minimal Record of Disability for Multiple Sclerosis (1985) U.S. National Multiple Sclerosis Society, New York
Mitchell JN (1981) Multiple sclerosis and the prospects for employment. J Soc Occup Med 31:134–138
Norušis MJ (1993) SPSS for Windows. Advanced Statistics Release 6.0. SPSS Inc., Chicago
Phillips VL (1995) Community care for severely disabled people on low incomes. BMJ 311:1121–1123
Riise T, Grønning M, Aarli JA, Nyland H, Larsen JP, Edland A (1988) Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol 41:1031–1036
Riise T, Grønning M, Fernández O, Lauer K, Midgard R, Minderhoud JM, Nyland H, Pálffy G, Poser S, Aarli JA (1992) Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand 85:212–218
Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurland LT (1994) Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology 44:28–33
Runmarker B, Andersen O (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116:117–134
Slater RJ, LaRocca NG, Scheinberg LC (1984) Development and testing of a minimal record of disability in multiple sclerosis. Ann NY Acad Sci 436:453–468
Stein REK, Gortmaker SL, Perrin EC, et al (1987) Severity of illness: concepts and measurements. Lancet II:1506–1509
Swingler RJ, Compston DAS (1992) The morbidity of multiple sclerosis. Q J Med 83:325–337
Weinshenker BG, Bass B, Rice GPA, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112:133–146
Willoughby EW, Paty DW (1988) Scales for rating impairment in multiple sclerosis: a critique. Neurology 38:1793–1798
Wood C (1994) The cost of multiple sclerosis — a pharmacoeconomic model. Mineo, University of Oxford
Zeldow PB, Pavlou M (1988) Physical and psychosocial functioning in multiple sclerosis: descriptions, correlations, and a tentative typology. Br J Med Psychol 61:185–195
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Midgard, R., Rüse, T. & Nyland, H. Impairment, disability and handicap in multiple sclerosis A cross-sectional study in an incident cohort in Møre and Romsdal County, Norway. J Neurol 243, 337–344 (1996). https://doi.org/10.1007/BF00868408
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00868408